Patient Blood Management: Anesthesiologist's Perspectives

Taehee Kim, M. Jeong
{"title":"Patient Blood Management: Anesthesiologist's Perspectives","authors":"Taehee Kim, M. Jeong","doi":"10.7599/HMR.2018.38.1.49","DOIUrl":null,"url":null,"abstract":"Blood transfusion is generally considered to be the solution of anemia and blood loss during surgery. Transfusion is a very efficient and effective method to correct anemia, but there has been increasing evidence that blood transfusion does not lead to improved outcomes and that morbidity and mortality increase in a dose-dependent manner [1,2]. It has been shown that even a single unit of transfused packed red blood cells (PRBCs) can increase 30day mortality, complicated mortality, pneumonia and sepsis [3]. Therefore, it is preferable to avoid unnecessary blood transfusion or to minimize blood transfusion. In surgical patients, patient blood management focuses on anemia management, minimization of blood loss, appropriate transfusion for reducing surgical risk, and improving patient outcome after surgery. Recognition and management of pre-operative anemia represent an opportunity to optimize patient status before surgery, thereby reducing blood transfusion and potentially improving recovery from surgery and associated postoperative outcomes. A complex approach such as anesthetic strategy and operative techniques, pharmacological intervention, and cell salvage is required to reduce bleeding during surgery. In this review, we reviewed the studies about blood management in the stance of anesthesiologists. Management of coagulopathy and blood component therapy was not included in this review.","PeriodicalId":345710,"journal":{"name":"Hanyang Medical Reviews","volume":"359 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hanyang Medical Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7599/HMR.2018.38.1.49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Blood transfusion is generally considered to be the solution of anemia and blood loss during surgery. Transfusion is a very efficient and effective method to correct anemia, but there has been increasing evidence that blood transfusion does not lead to improved outcomes and that morbidity and mortality increase in a dose-dependent manner [1,2]. It has been shown that even a single unit of transfused packed red blood cells (PRBCs) can increase 30day mortality, complicated mortality, pneumonia and sepsis [3]. Therefore, it is preferable to avoid unnecessary blood transfusion or to minimize blood transfusion. In surgical patients, patient blood management focuses on anemia management, minimization of blood loss, appropriate transfusion for reducing surgical risk, and improving patient outcome after surgery. Recognition and management of pre-operative anemia represent an opportunity to optimize patient status before surgery, thereby reducing blood transfusion and potentially improving recovery from surgery and associated postoperative outcomes. A complex approach such as anesthetic strategy and operative techniques, pharmacological intervention, and cell salvage is required to reduce bleeding during surgery. In this review, we reviewed the studies about blood management in the stance of anesthesiologists. Management of coagulopathy and blood component therapy was not included in this review.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
病人血液管理:麻醉师的观点
输血通常被认为是解决手术中贫血和失血的方法。输血是纠正贫血的一种非常高效和有效的方法,但越来越多的证据表明输血不能改善预后,而且发病率和死亡率呈剂量依赖性增加[1,2]。有研究表明,即使输入一个单位的填充红细胞(红细胞)也会增加30天死亡率、并发症死亡率、肺炎和败血症[3]。因此,最好避免不必要的输血或尽量减少输血。在外科患者中,患者血液管理的重点是贫血管理,尽量减少失血,适当输血以降低手术风险,改善术后患者预后。术前贫血的识别和管理是在手术前优化患者状态的一个机会,从而减少输血,并可能提高手术恢复和相关的术后结果。为了减少术中出血,需要采用复杂的方法,如麻醉策略和手术技术、药物干预和细胞抢救。本文从麻醉医师的角度对血液管理的研究进行综述。凝血功能障碍的治疗和血液成分治疗未包括在本综述中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Human Resistome Study with Metagenomic Sequencing Data Human Microbiome and Resistome Studies Carbapenem-resistant Enterobacteriaceae in Korea Microbiological Characteristics of Corynebacterium striatum, an Emerging Pathogen Microbiome of Hepatobiliary Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1